Latest Articles
The travel toll of living with endometriosis in regional Australia - Australian Broadcasting Corporation
The travel toll of living with endometriosis in regional Australia Australian Broadcasting Corporation
Published: April 20, 2025, 9:37 p.m.
Conceiving With Endometriosis: What Strategies Can Increase Your Chances? - OnlyMyHealth
Conceiving With Endometriosis: What Strategies Can Increase Your Chances? OnlyMyHealth
Published: April 20, 2025, 7:24 p.m.
Adenomyosis affects as many women as endometriosis, so why is it virtually unknown? - Glamour UK
Adenomyosis affects as many women as endometriosis, so why is it virtually unknown? Glamour UK
Published: April 20, 2025, 10 a.m.
A Battle With Endometriosis - GiveSendGo
A Battle With Endometriosis GiveSendGo
Published: April 19, 2025, 10:41 p.m.
Identification and validation of a novel machine learning model for predicting severe pelvic endometriosis: A retrospective study - Nature
Identification and validation of a novel machine learning model for predicting severe pelvic endometriosis: A retrospective study Nature
Published: April 19, 2025, 8:07 p.m.
Reproductive endocrinology and fertility fellowship with UW Health expands access to care - WIFR
Reproductive endocrinology and fertility fellowship with UW Health expands access to care WIFR
Published: April 19, 2025, 1:52 a.m.
Pearsanta to begin study of endometriosis test with IRB approval - MSN
Pearsanta to begin study of endometriosis test with IRB approval MSN
Published: April 19, 2025, 1:06 a.m.
The First Endometriosis Surgeries Were Successfully Performed In Hospital Azar - EIN News
The First Endometriosis Surgeries Were Successfully Performed In Hospital Azar EIN News
Published: April 18, 2025, 9:33 p.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive
Published: April 18, 2025, 3:54 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …
Published: April 18, 2025, 5:25 a.m.
Link copied to clipboard!